rugada syndrome (BS) is characterized by ST-segment elevation in leads V1-3 with a right bundle branch block pattern and nocturnal sudden cardiac death caused by ventricular fibrillation (VF). 1, 2 Patients with this syndrome who have experienced syncopal episodes or have been resuscitated from cardiac arrest have a poor prognosis if they do not receive an implantable cardioverter defibrillator (ICD). Although the prevalence of Brugadatype ECG change in healthy subjects is approximately 0.1-1%, their prognosis of is relatively good compared with symptomatic patients. 3-10 However, some asymptomatic patients become symptomatic and sudden cardiac death can occur with the first VF attack, so it is a problem in Japan of how to treat asymptomatic patients with a typical Brugadatype ECG who are detected by daily medical check-up. The results of some recent studies regarding the prognostic value of programmed electrical stimulation (PES) for patients with BS are conflicting; 6-9 Priori et al reported that the factors that predicted cardiac events were spontaneous ST elevation in leads V1-3 and episodes of syncope, but that VF inducible by PES did not indicate an increased risk of cardiac arrest, 7 whereas Brugada et al reported that inducibility of ventricular arrhythmia and an abnormal ECG without provocation were predictors of arrhythmic events. 8, 9 However, an electrophysiological study (EPS) is expensive and invasive, and sometimes results in complications, so it should not be carried out for all asymptomatic patients who show a Brugada-type ECG, but only for those patients for whom there is a high risk for a cardiac event. Because it is currently impossible to accurately predict the occurrence of cardiac events in asymptomatic patients, the present study was designed to determine noninvasive methods that could predict induction of VF by PES in asymptomatic patients with Brugada syndrome. For this purpose, the clinical characteristics of asymptomatic patients in whom VF was induced by PES were assessed, and the differences between the clinical values in asymptomatic patients with PESinduced VF and those without PES-induced VF were studied using noninvasive methods (a sodium channel blocker [pilsicainide] challenge test and a signal averaged electrogram).
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had right bundle branch block with spontaneous ST elevation without drug provocation. Two patients had a family history of unexplained sudden death at less than 50 years of age, but there was no obvious family history of BS. Echocardiography, right ventriculography and cardiac biopsy from the inter-ventricular septum of the right ventricle were performed in all patients but no abnormalities were found.
Classification of the Patients
The patients were divided into 2 groups based on the results of the EPS: one group in which VF was induced by PES (inducible VF group, n=13) and one group in which VF was not induced by PES (non-inducible VF group, n=28).
Pharmacological Challenge With a Sodium Channel Blocker
Pilsicainide was administered to all patients (150 mg po in 14 patients; 1 mg/kg iv over a 6-min period in 27 patients) and the ST level was measured at the J point in leads V1 and V2, before and after administration of pilsicainide, to calculate the difference in the ST level ( ST). The occurrence of ventricular arrhythmia after administration of pilsicainide was also evaluated.
Signal Averaged Electrogram
The presence of an abnormal late potential (LP) was investigated using a signal-averaged electrogram (SAECG: ART 1200EPX, noise level <0.3 V, high-pass filtering of 40 Hz using a bi-directional four-pole Butterworth). The filtered QRS duration, the root mean square voltage of the terminal 40 ms in the filtered QRS complex (RMS40), and the duration of low-amplitude signals (<40 V) in the terminal filtered QRS complex (LAS40) were measured using the SAECG. The LP was considered to be positive when 2 criteria were met (RMS40 <20 V and LAS40 >38 ms).
Electrophysiological Study
After obtaining written informed consent, an EPS was performed in all 41 patients with BS. All antiarrhythmic drugs were discontinued for at least 5 drug half-lives beforehand. PES was performed at an intensity twice the threshold for 2 ms through the distal electrodes placed at the right ventricular apex (RVA), the right ventricular outflow tract (RVOT) and the left ventricle (LV), using a SEC3105 Nihon-Koden pulse generator. The protocol included an 8-beat ventricular paced drive train at 2 basic cycle lengths (600 and 400 ms) followed by a decremental introduction of up to triple extrastimuli and 5-beat rapid burst pacing up to 270 beats/min. The coupling interval of extrastimuli was not less than 180 ms. The end-point was either induction of VF or completion of the protocol. VF was defined as an ECG consisting of chaotic deflections of varying amplitude and counter.
Statistical Analysis
Quantitative values are expressed as means ± 1SD. Statis- 
Results

Clinical Characteristics in Asymptomatic Patient With BS
The ST levels at leads V1 and V2 were augmented after administration of pilsicainide (Table 1) . A ventricular arrhythmia occurred spontaneously in 4 (9.8%) of the asymptomatic patients after administration of pilsicainide: premature ventricular contractions in 3 patients and polymorphic ventricular tachycardia in 1 patient. The SAECG often showed abnormal values. During the EPS, VF was induced in 13 (31.8 %) of the patients, but not in 28 (68.3%).
Differences Between the Clinical Characteristics of the Inducible VF and Non-Inducible VF Groups
The ST levels in the right precordial leads were augmented after administration of pilsicainide in both groups, and there were no differences in the ST level in lead V1 between the groups (Table 1, Fig 1a) . The voltage of the ST level in lead V2 was significantly high at rest and was augmented after administration of pilsicainide in the inducible VF group compared with the non-inducible VF group (Fig 1b) . There was no difference between the ST of V1 in either group, but ST of V2 was significantly augmented in the inducible VF group (Fig 2) . Ventricular arrhythmia occurred after administration of pilsicainide in 3 patients in the inducible VF group and in 1 patient in the non-inducible VF group, and the SAECG showed abnormal values more frequently in the inducible VF group than in the in non-inducible VF group (Figs 3-5) .
The ST level at rest, the ST with pilsicainide challenge and the LP all showed high sensitivity, but low specificity for detection of induction of VF by PES in the asymptomatic patients individually. The sensitivity and specificity of the ST level in V2 >0.15 mV at baseline were 100% and 21%, respectively, of ST at rest >0.1 mV in V2 with administration of pilsicainide were 100% and 54%, respectively, and of the positive late potential of RMS40 >38 V and LAS40 <20 ms were 92% and 64%, respectively. A ST of the induced VF group was larger than that of the non-induced VF group. combination of all these values showed high sensitivity (92%) and specificity (89%) for detection of induction of VF by PES in asymptomatic patients.
Follow-up
The mean follow-up period for the patients was 28±24 months (range, 1-77 months). There was no difference between the follow-up periods for patients in the inducible VF group (average 18±16 months; range, 1-65 months) and those in the non-inducible VF group (average 33±26 months; range, 1-77 months, p=0.076). New cardiac events (ie, syncope, sudden death or documented VF) did not occur in any of the patients.
Discussion
In 1992 Brugada et al reported patients who had VF with a right bundle branch morphology and ST-segment elevation at rest, 1 and it has since been reported that the VF can be induced by PES in most symptomatic patients with BS and in approximately 30% of asymptomatic patients, although the results regarding the prognostic value of inducing VF are conflicting. [6] [7] [8] [9] [10] Although the prevalence of Brugada-type ECG change is approximately 0.1-1% in healthy subjects, their prognosis has been reported as relatively good compared with symptomatic patients, 3-8 except for one early study. 11 However, some asymptomatic patients become symptomatic and in some patients sudden cardiac death can occur with the first VF attack. Therefore, a clinical examination that enables high-risk asymptomatic patients to be differentiated from those at low risk asymptomatic patients is essential. Some ECG markers have been suggested as the criterion of high-risk patients. 12, 13 Priori et al reported that spontaneous ST-segment elevation and a history of syncope predict high-risk patients, but PES failed to predict the spontaneous occurrence of VF. 7 Moreover, in symptomatic patients who had an unexplained syncope attack or had been resuscitated from cardiac arrest, induction of VF by PES did not predict the recurrence of a cardiac event. 14 Brugada et al reported that inducibility of ventricular arrhythmia and spontaneous ST elevation were predictors of the spontaneous occurrence of an arrhythmia, 8, 9, 11 and they also showed the effectiveness of PES for predicting arrhythmic events in asymptomatic patients. Both of the above studies showed that symptomatic patients with a typical Brugada-type ECG who did not received an ICD had a poor prognosis, but their results regarding the effectiveness of PES for predicting cardiac events in asymptomatic patients with a typical Brugada-type ECG were contradictory. Priori et al recommended that larger numbers of patients needed to be studied using the same protocol and with longer follow-up periods before conclusive statements can be made on the prognostic value of PES in patients with BS. 7 
ST Elevation and Administration of a Sodium Channel Blocker
The ST elevation in patients with BS has been explained by abnormal shortening of the epicardial action potential duration and phase 2 reentry at the right ventricle. [15] [16] [17] A sodium channel blocker unmasks or augments ST elevation 18 because a decrease in the sodium current induces a prominent transient outward current, which results in marked shortening of the epicardial action potential duration. 16 The results of the present study showed that ST levels in the right precordial leads were augmented by administration of pilsicainide in asymptomatic patients, particularly those with inducible VF, and we consider that the response of epicardial repolarization to a sodium channel blocker is more sensitive and augmented in the asymptomatic patients with PES-induced VF.
Ventricular Arrhythmia and Sodium Channel Blocker
Administration of pilsicainide induced ventricular arrhythmia in 4 patients, one of whom developed polymorphic ventricular tachycardia. The induction of ventricular arrhythmia by administration of pilsicainide was not associated with ST level and LP, and occurred frequently in the inducible VF group. It is thought that asymptomatic patients with pilsicainide-induced ventricular arrhythmia are at high risk for the development of cardiac events, but long-term follow-up is needed to confirm this finding.
Late Potential and Conduction Abnormality
Although ST elevation has been explained by a repolarization abnormality, the conduction abnormality in patients with BS has been demonstrated clinically. Late activation in the right ventricle has been demonstrated by body surface mapping 19 and SAE has shown abnormal LP. [20] [21] [22] [23] A morphological abnormality in the right ventricle also has been shown 24 and recently, Nagase et al reported that an epicardial conduction abnormality exists in patients with BS. 25 Moreover, we have reported that a conduction abnormality exists not only in the ventricular myocardium, but also in the atrial myocardium. 26 The present study showed that abnormal LP was frequent in asymptomatic patients, especially in those with PES-induced VF, indicating that a conduction abnormality is an underlying factor in asymptomatic patients with BS in whom VF can be induced by PES. This finding is similar to the results of a recent study in which electrophysiologic characteristics were studied in symptomatic patients with BS, 14 and our results indicate that repolarization and depolarization abnormalities play an important role in the induction of VF by PES and in the spontaneous occurrence of ventricular arrhythmia.
Sensitivity and Specificity for Detection of PES-Induced Ventricular Fibrillation
The ST level at rest, the augmentation of the ST level by pilsicainide and the LP were evaluated in the asymptomatic patients with BS and we found that these indices were more abnormal in the asymptomatic patients with PES-induced VF. The sensitivity of these indices for detection of PESinduced VF was high, but the specificity of each of these indices was quite low. A combination of these indices had high sensitivity and improved specificity for detection of induction of VF by PES. Although it is not clear whether these combined indices are useful for predicting the prognosis of patients with BS, an EPS could be omitted if these indices was positive in asymptomatic patients with BS.
Study Limitations
We were not able to detect genetic abnormalities, and the response to sodium channel blockade and occurrence of abnormal LP could depend on BS genotype. However, determining the genotype in BS is relatively difficult because the prevalence of mutations in the cardiac sodium channel is reportedly only 15%. 6 The ST levels in the right precordial leads can vary in patients with BS 28 and that an abnormal ECG can sometimes become normal. Although we conclude from the present results that a useful criterion of ST elevation is >0.15 mV in lead V2, some patients with a normalized ECG would not be detected by this criterion. Thus if a patient was susceptible for BS, the ECG recording should be repeated. Another limitation of this study is the relatively small number of patients and short follow-up periods, because this study was performed in one institute. Cardiac events did not occur in any of the asymptomatic patients, but further study is needed to determine the longterm prognosis of asymptomatic patients with BS.
We used intravenous and oral administration of pilsicainide, but we did not compare the serum drug concentration with the 2 administration methods and it is possible that the ST level and occurrence of ventricular arrhythmia after administration of pilsicainide might be influence by the route of administration.
Conclusions
Asymptomatic BS patients with induced ventricular fibrillation by PES have an abnormal repolarization response to administration of a sodium channel blocker and a conduction abnormality. The criterion of ST level (V2) at rest of >0.15 mV, augmentation of ST level (V2) after administration of pilsicainide of >0.1 mV, and positive LP (RMS40 >38 V and LAS40 <20 ms) have high specificity and sensitivity for detection of PES-induced VF in asymptomatic patients with BS.
